FDA Warning Letter — Rowpar Pharmaceuticals
The FDA took a Warning Letter action against Rowpar Pharmaceuticals on Dec 18, 2020 (Scottsdale, AZ). The action was issued by CDER and concerns drugs products.
Action Details
- Facility
- Rowpar Pharmaceuticals
- Date
- Dec 18, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Center
- CDER
- Location
- Scottsdale, AZ (United States)